The effect of splenopentin (DA SP-5) on In vitro myelopoiesis and on azt-induced bone marrow toxicity

Audhya, 1984, Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen, 81, 2847 Brandt, 1988, Effect of recombinant human granulocyte - macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation, New Engl. J. Med., 318, 869, 10.1056/NEJM198804073181401 Champlin, 1988, Granulocyte - macrophage colony-stimulating factor (GM-CSF) treatment for aplastic anemia (AA) or agranulocytosis, Expl Hemat., 16, 519 De Angelis, 1986, Thymopentin, Drugs Today, 22, 20 Diezel, 1986, Effect of splenopentin (SP 5) on the antibody formation in immunosuppressed mice, Exp. clin. Endocrin., 87, 215, 10.1055/s-0029-1210547 Diezel, 1989, Synergistic effects of splenopentin and recombinant human granulocyte - macrophage colony stimulating factor on myelopoiesis, J. invest. Derm., 93, 547 Diezel, Induction and augmentation of mitogen induced immune interferon production in human lymphocytes by a synthetic pentapeptide, Biomed. biochim. Acta, 43, K9 Goldstein, 1979, A synthetic pentapeptide with biological activity characteristics of the thymic hormone thymopoietin, Science, 224, 204 Groopman, 1987, Effect of recombinant human granulocyte - macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome, New Engl. J. Med., 317, 593, 10.1056/NEJM198709033171003 Gruner, 1990, Stimulation of the recruitment of epidermal Langerhans cells by splenopentin, Arch. Derm. Res., 281, 526, 10.1007/BF00412738 Ihle, 1982, Procedures for the purification of interleukin-3 to homogenity, J. Immun., 129, 2431, 10.4049/jimmunol.129.6.2431 Katz, 1979, Epidermal Langerhans cells are derived from cells originating in bone marrow, Nature, 282, 324, 10.1038/282324a0 Kawasaki, 1985, Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1), Science, 230, 291, 10.1126/science.2996129 Lenfant, 1989, Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure, 86, 779 Lovhaug, 1986, Monocyte-conditioned medium and interleukin-1 induce granulocyte - macrophage colony stimulating factor production in the adherent cell layer of murine bone marrow cultures, Expl Hemat., 14, 1037 Maciejewski, 1990, Cytofluorometric and cytomorphologic analysis of human bone marrow cells derived from stromal cultures stimulated by granulocyte macrophage colony-stimulating factor, interferon-gamma and splenopentin pentapeptide, Eur. J. Immun., 20, 1209, 10.1002/eji.1830200603 Metcalf, 1984 Metcalf, 1985, The granulocyte macrophage colony stimulating factors, Science, 229, 16, 10.1126/science.2990035 Moore, 1988, Interleukin-3: an overview, Lymphokines, 15, 219 Paukovits, 1990, Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide, Cancer Res., 50, 328 Pluda, 1990, Subcutaneous recombinant granulocyte - macrophage colony-stimulating factor used as a single agent and in an alternating regime with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection, Blood, 76, 463, 10.1182/blood.V76.3.463.463 Spooncer, 1986, Self-renewal and differentiation of interleukin-3 dependent multipotent stem cells are modulated by stromal cells and serum factors, Differentiation, 31, 111, 10.1111/j.1432-0436.1986.tb00391.x Stanley, 1984, Factors affecting the growth and differentiation of hemopoietic cells in culture, Clin. Haemat., 13, 329, 10.1016/S0308-2261(21)00426-4 Weber, 1990, Splenopentin (DA SP-5) accelerates the restoration of myelopoietic and immune systems after sublethal radiation in mice, Int. J. Immunopharmac., 12, 761, 10.1016/0192-0561(90)90040-T